Graves' disease and autoimmune factor VIII deficiency

Rubens Sievert, Mervyn L. Goldstein, Martin I. Surks

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

A patient with longstanding Hashimoto's thyroiditis who was treated with L-thyroxine at a dosage of 0.05 mg/day developed a decreased serum TSH concentration. L-Thyroxine was discontinued. Within 1 month, the patient developed mild hyperthyroidism due to Graves' disease. A hemorrhagic disorder occurred simultaneously with bleeding into muscle, joints, and skin. The bleeding disorder was identified as an acquired factor VIII deficiency due to a factor VIII inhibitor. The bleeding disorder resolved after treatment with prednisone, cyclophosphamide, and intravenous gamma globulin. Graves' disease also resolved but without specific treatment with either antithyroid drugs or radioactive iodine. The development of these two autoimmune disorders in this patient simultaneously suggests an underlying derangement in immune regulation common to both diseases.

Original languageEnglish (US)
Pages (from-to)245-247
Number of pages3
JournalThyroid
Volume6
Issue number3
Publication statusPublished - Sep 4 1996
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Sievert, R., Goldstein, M. L., & Surks, M. I. (1996). Graves' disease and autoimmune factor VIII deficiency. Thyroid, 6(3), 245-247.